WallStreetZenWallStreetZen

NASDAQ: PRAX
Praxis Precision Medicines Inc Stock Ownership - Who owns Praxis Precision Medicines?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Praxis Precision Medicines Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Timothy Edwin KellyChief Financial Officer2026-01-12943$275.74
$260.02kSell
Alex NemiroffGeneral Counsel and Secretary2026-01-12768$275.74
$211.77kSell
Megan SniecinskiChief Operating Officer2026-01-12885$275.74
$244.03kSell
Lauren MastrocolaPrincipal Accounting Officer2026-01-12344$275.74
$94.85kSell
Timothy Edwin KellyChief Financial Officer2026-01-101,335$288.45
$385.08kSell
Marcio SouzaChief Executive Officer2026-01-104,252$288.45
$1.23MSell
Megan SniecinskiChief Operating Officer2026-01-101,087$288.45
$313.55kSell
Alex NemiroffGeneral Counsel and Secretary2026-01-10917$288.45
$264.51kSell
Lauren MastrocolaPrincipal Accounting Officer2026-01-10367$288.45
$105.86kSell
Timothy Edwin KellyChief Financial Officer2026-01-07139$292.63
$40.68kSell

1 of 5

PRAX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PRAX insiders and whales buy or sell their stock.

PRAX Shareholders

What type of owners hold Praxis Precision Medicines Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bsof Parallel Master Fund LP17.57%4,894,109$1.67BInsider
Janus Henderson Group PLC11.63%3,240,086$1.10BInstitution
Stefan Vitorovic10.55%2,939,329$1.00BInsider
Holdings A. Novo8.77%2,442,080$831.45MInsider
Blackrock Inc7.46%2,078,500$707.67MInstitution
Adage Capital Management LP7.40%2,060,175$701.43MInsider
Perceptive Advisors LLC7.17%1,995,986$679.57MInstitution
Vanguard Group Inc5.25%1,460,933$497.40MInstitution
Fmr LLC4.88%1,358,675$462.59MInstitution
Orbis Allan Gray Ltd4.51%1,255,162$427.35MInstitution

1 of 3

PRAX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PRAX67.65%32.35%Net SellingNet Selling
TECH97.78%2.22%Net BuyingNet Selling
PCVX88.13%11.87%Net SellingNet Selling
ARWR82.89%9.85%Net SellingNet Selling
MDGL26.13%73.87%Net BuyingNet Selling
View Top Biotech Stocks

Praxis Precision Medicines Stock Ownership FAQ

Who owns Praxis Precision Medicines?

Praxis Precision Medicines (NASDAQ: PRAX) is owned by 105.81% institutional shareholders, 50.60% Praxis Precision Medicines insiders, and 0.00% retail investors. Bsof Parallel Master Fund LP is the largest individual Praxis Precision Medicines shareholder, owning 4.89M shares representing 17.57% of the company. Bsof Parallel Master Fund LP's Praxis Precision Medicines shares are currently valued at $1.65B.

If you're new to stock investing, here's how to buy Praxis Precision Medicines stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.